Prosecution Insights
Last updated: November 16, 2026
Application No. 18/663,913

INTEGRATED SURGICAL SYSTEM AND METHOD FOR TREATMENT IN THE IRIDO-CORNEAL ANGLE OF THE EYE

Non-Final OA §112§DP
Filed
May 14, 2024
Priority
Jul 16, 2018 — divisional of 10/821,023 +1 more
Examiner
GHAND, JENNIFER LEIGH-STEWAR
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Vialase Inc.
OA Round
1 (Non-Final)
61%
Grant Probability
Moderate
1-2
OA Rounds
89%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
417 granted / 688 resolved
-9.4% vs TC avg
Strong +28% interview lift
Without
With
+28.0%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
52 currently pending
Career history
770
Total Applications
across all art units

Office Action

§112 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election of Invention I, claims 1-14 in the reply filed on 7/1/2026 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Claims 15-24 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 7/1/2026. Information Disclosure Statement Applicant should note that the large number of references in the attached IDS, see IDS filed 5/14/2024, have been considered by the examiner in the same manner as other documents in Office search files are considered by the examiner while conducting a search of the prior art in a proper filed of search. See MPEP 609.05(b). Applicant is requested to point out any particular references in the IDS which they believe may be of particular relevance to the instant claimed invention in response to this Office Action. Specification The disclosure is objected to because of the following informalities: Related application 17/0003805 has issued into a patent. Paragraph [0001] should be updated to include the issued patent number. Appropriate correction is required. The lengthy specification has not been checked to the extent necessary to determine the presence of all possible minor errors. Applicant’s cooperation is requested in correcting any errors of which applicant may become aware in the specification. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “optical assembly configured to..” in claims 1-14, “intermediate optical assembly configured to..” in claims 11-12 and 14. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. Specifically “optical assembly” and “intermediate optical assembly” have been interpreted to include one or more planar beam-folding mirrors, prisms (not shown) or optical gratings (not shown) configured to receive the optical output and equivalents thereof, see elements 1002, 1004 and para. [0101] of published application US 2024/0299215. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 9-10 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 9 recites “visual observation device 400” it is unclear whether applicant is referring to a certain type of observation device or if applicant is providing the reference numeral for the observation device, clarification is required. If applicant is providing the reference numeral it should be provided within parenthesis. Claim 10 recites “third light source 400” it is unclear whether applicant is referring to a certain type of light source or if applicant is providing the reference numeral for the third light source, clarification is required. If applicant is providing the reference numeral it should be provided within parenthesis. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-3 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1,3 and 8-9 of U.S. Patent No.12,746,154. Although the claims at issue are not identical, they are not patentably distinct from each other because both the claims in the instant application and U.S. Patent No.12,746,154 recite a system for delivering light beams to an irido-corneal angle of the eye that includes an exit lens, at least one light source and an optical assembly to receive the light beam and direct the light beam to the beam input surface of the exit lens along an angled beam path that extends through the exit lens at an angle relative to the first optical axis in which the optical assembly rotates independent of the exit lens, with the claims in the instant application being more generic, see claim chart below. The entire scope of the claims 1-3 in the instant application falls within the scope of claims 1,3 and 8-9 of U.S. Patent No.12,746,154, therefore a patent to the generic claims within the instant application would improperly extend the right to exclude granted by of U.S. Patent No.12,746,154, see claim chart below and MPEP 804. Instant Application US Patent No. 12,746,154 Analysis 1. (Original) A system for delivering one or more light beams to an irido-corneal angle of an eye, the system comprising: a housing having an eye-facing end; an exit lens at the eye-facing end of the housing, the exit lens having a beam exit surface configured to face the eye, a beam input surface opposite the beam exit surface, and a first optical axis extending through the apex of the beam exit surface and the apex of the beam input surface; at least one light source that outputs a light beam; and an optical assembly within the housing and interposed between the at least one light source and the exit lens, the optical assembly configured to: receive the light beam and direct the light beam to the beam input surface of the exit lens along an angled beam path that extends through the exit lens at an angle relative to the first optical axis, and rotate about the first optical axis without rotating the exit lens. 1. An integrated surgical system for treating an eye, the integrated surgical system comprising: a laser source configured to output a laser beam; an exit lens configured to optically couple to a cornea, the exit lens having an input surface, an output surface opposite the input surface, and a first optical axis that extends through an apex of the input surface and the apex of the output surface; one or more laser scanner components optically coupled to receive the laser beam; an optical assembly optically coupled to receive the laser beam and direct the laser beam into the input surface of the exit lens along an angled beam path that extends through the cornea, through an anterior chamber, and into an irido-corneal angle, wherein the optical assembly is configured to rotate around the first optical axis independent of corresponding movement of the exit lens; and a control system coupled to the laser source and the one or more laser scanner components, and configured to: instruct the one or more laser scanner components to scan the laser beam through a volume within a Schlemm's canal, and instruct the laser source to apply laser energy through the laser beam while the laser beam is scanned through the volume, wherein the laser energy is configured to create a pneumatic effect that expands the Schlemm's canal. Claim 1 of the instant application and claim 1 of U.S. Patent No.12,746,154 recite almost identical system for delivering light beams to an irido-corneal angle of the eye that includes an exit lens, at least one light source and an optical assembly to receive the light beam and direct the light beam to the beam input surface of the exit lens along an angled beam path that extends through the exit lens at an angle relative to the first optical axis in which the optical assembly rotates independent of the exit lens. Claim 1 of the instant application is more generic and has a scope that falls within and is fully anticipated by clam 1 of U.S. Patent No.12,746,154. 2. (Original) The system of claim 1, wherein the at least one light source comprises a laser source and the light beam is a laser beam, the system further comprising: a laser-beam scanner within the housing and optically positioned to receive the laser beam from the laser source and to direct the laser beam to the optical assembly, wherein the laser-beam scanner is configured to rotate about the first optical axis without rotating the exit lens. 1. An integrated surgical system for treating an eye, the integrated surgical system comprising: a laser source configured to output a laser beam; an exit lens configured to optically couple to a cornea, the exit lens having an input surface, an output surface opposite the input surface, and a first optical axis that extends through an apex of the input surface and the apex of the output surface; one or more laser scanner components optically coupled to receive the laser beam; an optical assembly optically coupled to receive the laser beam and direct the laser beam into the input surface of the exit lens along an angled beam path that extends through the cornea, through an anterior chamber, and into an irido-corneal angle, wherein the optical assembly is configured to rotate around the first optical axis independent of corresponding movement of the exit lens; and a control system coupled to the laser source and the one or more laser scanner components, and configured to: instruct the one or more laser scanner components to scan the laser beam through a volume within a Schlemm's canal, and instruct the laser source to apply laser energy through the laser beam while the laser beam is scanned through the volume, wherein the laser energy is configured to create a pneumatic effect that expands the Schlemm's canal. 3. The integrated surgical system of claim 1, wherein one or more components of the one or more laser scanner components is configured to rotate with the optical assembly. See analysis above regarding claim 1 being anticipated by claim 1 of U.S. Patent No.12,746,154. The limitations recited within claim 2 of the instant application are fully disclosed within claims 1 and 3 of U.S. Patent No.12,746,154. 3. (Original) The system of claim 1, wherein the at least one light source comprises optical coherence tomography (OCT) apparatus and the light beam is an OCT beam, the system further comprising: OCT-beam scanner within the housing and optically positioned to receive the OCT beam from the OCT apparatus and to direct the OCT beam to the optical assembly, wherein the OCT- beam scanner is configured to rotate about the first optical axis without rotating the exit lens. 8. The integrated surgical system of claim 1, further comprising: an OCT apparatus configured to output an OCT beam; and one or more OCT scanner components optically coupled to receive the OCT beam, wherein, the optical assembly is optically coupled to receive the OCT beam and direct the OCT beam into the input surface of the exit lens along the angled beam path that extends through the cornea, through an anterior chamber, and into an irido-corneal angle. 9. The integrated surgical system of claim 8, wherein: one or more components of the one or more OCT scanner components is configured to rotate with the optical assembly. See analysis above regarding claim 1 being anticipated by claim 1 of U.S. Patent No.12,746,154. The limitations recited within claim 3 of the instant application are fully disclosed within claims 8 and 9 of U.S. Patent No.12,746,154. Claims 1-3 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1,3 and 11-12 of U.S. Patent No. 12,115,105. Although the claims at issue are not identical, they are not patentably distinct from each other because both the claims in the instant application and U.S. Patent No. 12,115,105 recite a system for delivering light beams to an irido-corneal angle of the eye that includes an exit lens, at least one light source and an optical assembly to receive the light beam and direct the light beam to the beam input surface of the exit lens along an angled beam path that extends through the exit lens at an angle relative to the first optical axis in which the optical assembly rotates independent of the exit lens, with the claims in the instant application being more generic, see claim chart below. The entire scope of the claims 1-3 in the instant application falls within the scope of claims 1,3 and 11-12 of U.S. Patent No. 12,115,105, therefore a patent to the generic claims within the instant application would improperly extend the right to exclude granted by of U.S. Patent No. 12,115,105, see claim chart below and MPEP 804. Instant Application US Patent No. 12,115,105 Analysis 1. (Original) A system for delivering one or more light beams to an irido-corneal angle of an eye, the system comprising: a housing having an eye-facing end; an exit lens at the eye-facing end of the housing, the exit lens having a beam exit surface configured to face the eye, a beam input surface opposite the beam exit surface, and a first optical axis extending through the apex of the beam exit surface and the apex of the beam input surface; at least one light source that outputs a light beam; and an optical assembly within the housing and interposed between the at least one light source and the exit lens, the optical assembly configured to: receive the light beam and direct the light beam to the beam input surface of the exit lens along an angled beam path that extends through the exit lens at an angle relative to the first optical axis, and rotate about the first optical axis without rotating the exit lens. 1. An integrated surgical system for treating an eye, the integrated surgical system comprising: a laser source configured to output a laser beam; an exit lens configured to optically couple to a cornea, the exit lens having an input surface, an output surface opposite the input surface, and a first optical axis that extends through the apex of the input surface and the apex of the output surface; one or more laser scanner components optically coupled to receive the laser beam; an optical assembly optically coupled to receive the laser beam and direct the laser beam into the input surface of the exit lens along an angled beam path that extends through the cornea, through an anterior chamber, and into an irido-corneal angle, wherein the optical assembly is configured to rotate around the first optical axis independent of corresponding movement of the exit lens; and a control system coupled to the laser source and the one or more laser scanner components, and configured to treat a volume of ocular tissue that extends partially through a trabecular meshwork of the eye based on a treatment plan, the control system configured to: instruct the one or more laser scanner components to scan the laser beam through a volume of ocular tissue in accordance with the treatment plan, and instruct the laser source to apply laser energy through the laser beam while the laser beam is scanned through the volume of ocular tissue, wherein the laser energy is configured to cause a photo-disruptive interaction with the ocular tissue. Claim 1 of the instant application and claim 1 of U.S. Patent No.12,115,105 recite a system for delivering light beams to an irido-corneal angle of the eye that includes an exit lens, at least one light source and an optical assembly to receive the light beam and direct the light beam to the beam input surface of the exit lens along an angled beam path that extends through the exit lens at an angle relative to the first optical axis in which the optical assembly rotates independent of the exit lens. Claim 1 of the instant application is more generic and has a scope that falls within and is fully anticipated by clam 1 of U.S. Patent No. 12,115,105. 2. (Original) The system of claim 1, wherein the at least one light source comprises a laser source and the light beam is a laser beam, the system further comprising: a laser-beam scanner within the housing and optically positioned to receive the laser beam from the laser source and to direct the laser beam to the optical assembly, wherein the laser-beam scanner is configured to rotate about the first optical axis without rotating the exit lens. 1. An integrated surgical system for treating an eye, the integrated surgical system comprising: a laser source configured to output a laser beam; an exit lens configured to optically couple to a cornea, the exit lens having an input surface, an output surface opposite the input surface, and a first optical axis that extends through the apex of the input surface and the apex of the output surface; one or more laser scanner components optically coupled to receive the laser beam; an optical assembly optically coupled to receive the laser beam and direct the laser beam into the input surface of the exit lens along an angled beam path that extends through the cornea, through an anterior chamber, and into an irido-corneal angle, wherein the optical assembly is configured to rotate around the first optical axis independent of corresponding movement of the exit lens; and a control system coupled to the laser source and the one or more laser scanner components, and configured to treat a volume of ocular tissue that extends partially through a trabecular meshwork of the eye based on a treatment plan, the control system configured to: instruct the one or more laser scanner components to scan the laser beam through a volume of ocular tissue in accordance with the treatment plan, and instruct the laser source to apply laser energy through the laser beam while the laser beam is scanned through the volume of ocular tissue, wherein the laser energy is configured to cause a photo-disruptive interaction with the ocular tissue. 3. The integrated surgical system of claim 1, wherein one or more components of the one or more laser scanner components is configured to rotate with the optical assembly. See analysis above regarding claim 1 being anticipated by claim 1 of U.S. Patent No.12,115,105. The limitations recited within claim 2 of the instant application are fully disclosed within claims 1 and 3 of U.S. Patent No. 12,115,105. 3. (Original) The system of claim 1, wherein the at least one light source comprises optical coherence tomography (OCT) apparatus and the light beam is an OCT beam, the system further comprising: OCT-beam scanner within the housing and optically positioned to receive the OCT beam from the OCT apparatus and to direct the OCT beam to the optical assembly, wherein the OCT- beam scanner is configured to rotate about the first optical axis without rotating the exit lens. 11. The integrated surgical system of claim 1, further comprising: an OCT apparatus configured to output an OCT beam; and one or more OCT scanner components optically coupled to receive the OCT beam, wherein, the optical assembly is optically coupled to receive the OCT beam and direct the OCT beam into the input surface of the exit lens along the angled beam path that extends through the cornea, through an anterior chamber, and into an irido-corneal angle. 12. The integrated surgical system of claim 11, wherein: one or more components of the one or more OCT scanner components is configured to rotate with the optical assembly. See analysis above regarding claim 1 being anticipated by claim 1 of U.S. Patent No.12,115,105. The limitations recited within claim 2 of the instant application are fully disclosed within claims 11 and 12 of U.S. Patent No. 12,115,105. Allowable Subject Matter Claims 4-8 and 11-14 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The prior art references alone and in combination fail to teach or remotely suggest a system for delivering one or more light beams to an irido-corneal angle of the eye as claimed within claims 4-8 and 11-14 of the instant invention. Vera et al. (US 9,033,963) discloses a system for delivering light beams to the eye that includes at least a housing, exit lens, light source and optical assembly. However, Vera does not disclose an exit lens having the recited structure and wherein the optical assembly is configured to rotate around an optical axis without corresponding movement of the exit lens, as recited within claims 4-8 and 11-14 of the instant invention. Tanassi et al. (US 2017/0231491) discloses an optical equipment for observation of an irido-corneal annular zone of an eye including an illumination assembly as shown in Fig. 6; the system comprises a light source, an exit lens, and an optical assembly (610) that rotates around the optical axis (600) independent of corresponding movement of an exit lens (608). However, Tanassi discloses an imaging system, not a system for delivering one or more light beams to an irido-corneal angle of an eye as recited within claims 4-8 and 11-14 of the instant invention. Raksi (US 2020/0016002) Figs. 8, 9a and 9b illustrates an ophthalmic surgical system that includes at least a housing, exit lens, light source and optical assembly of claim 1. However, this reference has the same inventor and assignee as the current application; thus, the reference does not qualify as prior art. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US 2014/0228825 to Gorschboth et al. which discloses interface devices for use during eye surgery. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JENNIFER L GHAND whose telephone number is (571)270-5844. The examiner can normally be reached Mon-Fri 7:30AM - 3:30PM ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JENNIFER MCDONALD can be reached at (571)270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JENNIFER L GHAND/Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

May 14, 2024
Application Filed
Oct 02, 2026
Non-Final Rejection mailed — §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788961
INTRAVASCULAR FLUID MOVEMENT DEVICES, SYSTEMS, AND METHODS OF USE
4y 0m to grant Granted Nov 10, 2026
Patent 12788521
WEARABLE HAPTIC SENSORY FEEDBACK SYSTEM FOR INTERVENTIONAL CARDIOLOGY PROCEDURES
3y 6m to grant Granted Nov 10, 2026
Patent 12788973
Neuromodulation to Modulate Glymphatic Clearance
2y 5m to grant Granted Nov 10, 2026
Patent 12778582
SURGICAL INSTRUMENT HOLDING DEVICE AND SURGERY ASSISTING DEVICE
4y 2m to grant Granted Nov 03, 2026
Patent 12766327
INTELLIGENT MODULARIZATION
10y 2m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
61%
Grant Probability
89%
With Interview (+28.0%)
Low
PTA Risk
Based on 688 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month